Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian F Tannock

Showing results (21-30 of 240) with videos related to

Pageof 24
Sort By:
The New England Journal of Medicine|January 21, 2026
European Study of Prostate Cancer Screening - 23-Year Follow-upDerek Raghavan, Ian F Tannock
JCO Oncology Practice|October 13, 2025
Conflict of Interest: Moving From Disclosure to AvoidanceIan F Tannock, Saroj Niraula
Journal of the National Cancer Institute|January 2, 2003
Placebo effects in oncologyGisèle Chvetzoff, Ian F Tannock
Nature Reviews. Clinical Oncology|September 3, 2025
Non-financial conflicts of interestSaroj Niraula, Ian F Tannock
Nature Clinical Practice. Oncology|July 17, 2008
Intermittent androgen blockade should be regarded as standard therapy in prostate cancerBostjan Seruga, Ian F Tannock
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2009
Up-front use of aromatase inhibitors as adjuvant therapy for breast cancer: the emperor has no clothesBostjan Seruga, Ian F Tannock
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Effect of the selective estrogen receptor modulator arzoxifene on repopulation of hormone-responsive breast cancer xenografts between courses of chemotherapyLicun Wu, Ian F Tannock
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
Selective estrogen receptor modulators as inhibitors of repopulation of human breast cancer cell lines after chemotherapyWu Licun, Ian F Tannock
Nature Reviews. Clinical Oncology|February 6, 2013
Breast cancer: Tamoxifen--when more might be betterCarlos Caldas, Ian F Tannock
Nature Reviews. Urology|December 4, 2009
Prostate cancer: Androgen deprivation therapy and bone lossEitan Amir, Ian F Tannock
Pageof 24

Showing results (21-30 of 240) with videos related to

Sort By:
Pageof 24
The New England Journal of Medicine|January 21, 2026
European Study of Prostate Cancer Screening - 23-Year Follow-upDerek Raghavan, Ian F Tannock
JCO Oncology Practice|October 13, 2025
Conflict of Interest: Moving From Disclosure to AvoidanceIan F Tannock, Saroj Niraula
Journal of the National Cancer Institute|January 2, 2003
Placebo effects in oncologyGisèle Chvetzoff, Ian F Tannock
Nature Reviews. Clinical Oncology|September 3, 2025
Non-financial conflicts of interestSaroj Niraula, Ian F Tannock
Nature Clinical Practice. Oncology|July 17, 2008
Intermittent androgen blockade should be regarded as standard therapy in prostate cancerBostjan Seruga, Ian F Tannock
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2009
Up-front use of aromatase inhibitors as adjuvant therapy for breast cancer: the emperor has no clothesBostjan Seruga, Ian F Tannock
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Effect of the selective estrogen receptor modulator arzoxifene on repopulation of hormone-responsive breast cancer xenografts between courses of chemotherapyLicun Wu, Ian F Tannock
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
Selective estrogen receptor modulators as inhibitors of repopulation of human breast cancer cell lines after chemotherapyWu Licun, Ian F Tannock
Nature Reviews. Clinical Oncology|February 6, 2013
Breast cancer: Tamoxifen--when more might be betterCarlos Caldas, Ian F Tannock
Nature Reviews. Urology|December 4, 2009
Prostate cancer: Androgen deprivation therapy and bone lossEitan Amir, Ian F Tannock
Pageof 24